Current status of lung transplantation

Area of Science:

• Medicine
• Pulmonology
• Transplant Surgery

Background:

• Lung transplantation has advanced significantly due to experienced clinicians and ongoing research.
• Despite progress, clinical challenges persist, impacting patient outcomes.

Purpose of the Study:

• To review current advancements and persistent challenges in lung transplantation.
• To highlight the role of clinical trials, immunosuppression management, and graft protection strategies.

Main Methods:

• Review of current clinical practices and ongoing research in lung transplantation.
• Discussion of therapeutic drug monitoring, fibroproliferation inhibitors, and management of gastroesophageal reflux disease.
• Analysis of graft damage mechanisms, including low-grade rejection and small vessel vasculitis.

Main Results:

• Clinical trials are evaluating new immunosuppressive agents.
• Therapeutic drug monitoring is crucial for minimizing complications like renal dysfunction.
• Fibroproliferation inhibitors and fundoplication are strategies to manage graft injury and reflux.
• Low-grade rejection, potentially causing bronchiolar ischemic injury, is recognized as a cause of graft loss.

Conclusions:

• Lung transplantation has matured, but significant challenges require ongoing attention.
• Effective management of immunosuppression, graft injury, and related conditions is vital for long-term success.